| Ytd | 78.23% | |
| 1y | 42.18% |
| Open | 53.52 | Prev Close | 53.95 | Low | 52.80 | High | 53.83 | Mkt Cap | 8.26B |
| Vol | 352.81K | Avg Vol | 2.39M | EPS | 2.91 | P/E | 18.54 | Forward P/E | 42.37 |
| Beta | 1.60 | Short Ratio | 15.25 | Inst. Own | 70.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 47.85 | 200-d Avg | 35.93 | 1yr Est | 58.00 |
TGTX News
NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy a
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings
B of A Securities analyst Alec Stranahan maintains TG Therapeutics (NASDAQ:TGTX) with a Underperf
TGTX initiates a phase II study evaluating Briumvi in adult patients with treatment-resistant schizo
HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy
TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial eval
Phase 2 trial to evaluate the effects of B-cell depletion with BRIUMVI in approximately 60 patients
TG Therapeutics continues to witness rising Briumvi demand. Investors are closely watching the sales
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
TG Therapeutics Inc. (NASDAQ:TGTX) shares are trading higher on Thursday as traders keep leaning int
TG Therapeutics stock is on an absolute rampage, climbing 70% in roughly the first six months of the
3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b
TG Therapeutics (TGTX) witnessed a jump in share price last session on above-average trading volume.
TG Therapeutics gains after positive phase I data for subcutaneous Briumvi in myasthenia gravis or M
US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% afte
TG Therapeutics, Inc. (TGTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026
82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed
TG Therapeutics (TGTX) reported earnings 30 days ago. What's next for the stock?
TG Therapeutics jumps 9.5% after phase I data show that subcutaneous Briumvi achieved over 60% bioav
TG Therapeutics, Inc.'s Phase 1 results of subcutaneous Briumvi are a major de-risking event for TG'
Shares of TG Therapeutics Inc (NASDAQ:TGTX) are climbing Wednesday afternoon following the release o
Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY
Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen curre
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced tha
Retail investors are preparing for another busy week of earnings season with more than 1,600 compani
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterl
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, l
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e
During Wednesday's morning trading, 254 companies set new 52-week highs.
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Wednesday